Home › News › Pharma Industry News › Archive

Pharmaceutical Industry News Archive

Get news By email or subscribe to our News feeds.

All News Consumer Pharma New Drugs Pipeline Clinical Trials

January 2008

January 3

Celgene/Pharmion Hart-Scott-Rodino (HSR) Thirty Day Waiting Period Expires Addex and Merck & Co., Inc. Enter License Agreement to Develop a Drug Candidate for Schizophrenia B-cell Chronic Lymphocytic Leukemia (B-CLL): Expanded Labeling for MabCampath in Europe Crucell Enters Agreement with Sanofi Pasteur for Next-generation Biologicals Against Rabies Phase Bioscience Announces New Collaboration with Centocor Research and Development Galapagos Enters Into Oncology Target Discovery Collaboration with Janssen Pharmaceutica Bruker AXS Announces Agreement to Acquire Elemental Analysis Company JUWE Laborgeraete GmbH Novacea Provides Corporate and Development Update Pfizer to Appeal Canadian Federal Court Ruling on Lipitor Patent; Court's Decision Will Have No Immediate Commercial Impact FDA Issues Communication Communication about an Ongoing Safety Review of ESAs

January 7

Magen BioSciences Licenses Dermatology Assets from Lilly Contract Research Organization Market - What Pharmaceutical and Biotechnology Companies Want Pfizer and Taisho Finalize Agreement for Novel Schizophrenia Drug Candidate VaxGen Provides Update on Raven Transaction Progress Boston Scientific Completes Sale of Auditory Business and Drug Pump Development Program Access Pharmaceuticals Closes Acquisition of Somanta Pharmaceuticals Encorium Group, Inc. Announces the Signing of a $2.0 Million Contract for Data Management Services for a Global Pharmaceutical Company ATMI Acquires LevTech Faust Pharmaceuticals Announces Research Agreement with Takeda Inclinix Secures $10 Million in Expansion Funding Omnicom's BBDO Invests in China's Shunya Communications Group NextGen Sciences Announces Commercial Alliance with Paragon Bioservices, Inc Boston Scientific Completes Sale of Cardiac Surgery and Vascular Surgery Businesses Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer To Develop and Commercialize RNAi Hepatitis C Drug The GVK BIO Clinical Pharmacology Unit Granted Major Accreditations Synovate Healthcare Boosts Global Oncology Portfolio Through Acquisition of Oncology Inc. FDA MedWatch - Bisphosphonates- Possible Cause of Severe and Sometimes Incapacitating Bone, Joint, and/or Muscle Pain MedImmune Broadens Focus of Venture Capital Fund to Include New Therapeutic Areas Cambrex Signs Agreement To Acquire ProSyntest AS Court of Appeals Upholds Verdicts in Favor of Cordis Corporation on Patents Infringed by Medtronic, Inc. and Boston Scientific Corporation

January 8

NicOx Signs Extension of Ophthalmology Agreement With Pfizer Cetero Research Adds DGD Research, Enhancing Their Therapeutic Capabilities and Expertise to Include Endocrinology and Metabolic Disorders Reckitt Benckiser Receives Hart-Scott-Rodino Antitrust Clearance for Acquisition of Adams Respiratory Therapeutics Cetero Research Adds DGD Research, Enhancing Their Therapeutic Capabilities and Expertise to Include Endocrinology and Metabolic Disorders Anthera Pharmaceuticals Acquires the Worldwide Rights to a BAFF Inhibitor for the Treatment of Lupus and Other Autoimmune Diseases Boston Scientific Announces Court Decision Seattle Genetics Earns Milestone Payment from Initiation of SGN-40 Phase Ib Clinical Trial in Combination with Rituxan for Non-Hodgkin Lymphoma Genzyme and Isis Announce Strategic Alliance Including Exclusive Worldwide License of Mipomersen Introducing Latest Study on 'Optimizing Partnerships with Contract Organizations: Effective Management, Key Issues and the Development of Virtual Pharmacos' ViroPharma Provides Update on Vancocin Committee on Energy and Commerce Opens Investigation into Celebrity Drug Endorsements FDA Warnings Affected Prescriptions of Antidepressants to Youth Removing Thimerosal from Vaccines Did Not Reduce Autism Cases in California PII Acquires Pharmaterials Ltd Iris Pharma and Clirophtha Merger Creates Unique Ophthalmology CRO Iris Pharma and Clirophtha Merger Creates Unique Ophthalmology CRO Biogen Idec and PDL BioPharma License the Rights to Develop Volociximab in Ophthalmic Indications to Ophthotech ResearchPoint Global Announces Addition of M2S to Network Acquisition of Lymphatix Brings VEGF Gene Rights and Technology to Catalyse Ark's Gene-Based Medicine Programmes Praxis' Patient Recruitment Campaign Saves 300 Days off Enrollment for Women's Health Study Genzyme Reports 21 Percent Increase in Fourth-Quarter Revenue Amgen Updates 2007 Adjusted EPS Guidance and Outlines 2008 Expense Outlook at the JP Morgan Healthcare Conference First Consulting Group Prevails at Court Hearing

January 17

QLT Announces Visudyne Sales for Fourth Quarter and Fiscal Year 2007 QLT Inc. Announces Initial Steps in Strategic Restructuring Ventana Responds to Extension of Roche's Unsolicited Tender Offer Novartis Achieves Record Results in 2007 Underscoring Benefits of Strategic Healthcare Portfolio Reps. Dingell, Stupak Raise Concerns, Questions on ENHANCE Trial AAJ Demands FDA Withdraw Rule Allowing Drug Companies to Claim Immunity for Failing to Warn Patients of Potential Drug Hazards FDA MedWatch - Edetate Disodium (marketed as Endrate and generic products) - Important Safety Considerations For Healthcare Professionals Eisai and MGI Pharma Announce Early Termination of HSR Waiting Period for Eisai's Acquisition of MGI Pharma Genedata Provides Expressionist Platform to Eisai Research Institute Malvern Instruments Acquires Viscotek Corporation

January 18

Jan Marini Skin Research Suspends Sales of Popular Eyelash Products StemCells, Inc. Provides Batten's Clinical Trial Update Actavis Acquires Italian Manufacturing Site from Pfizer Roche Invests 430 Million Swiss Francs at Sites in Germany and Switzerland Centres for the Research, Development, Production and Filling of Innovative Biopharmaceuticals to be Expanded U.S. Appeals Court Upholds Finding that Abbott Infringed Innogenetics’ HCV Genotyping Patent, and Orders Abbott to Pay Innogenetics Monetary Damages and Sanctions Pfizer Statement on Chantix (varenicline) Labeling Update in the United States GTC Biotherapeutics Receives Notice Related to Nasdaq Minimum Closing Bid Price Rule Schering-Plough CEO to Buy $2 Million in Common Shares New Jersey Attorney General Announces Subpoena of Pharmaceutical Firm Over Marketing of Injectable Drug Enbrel

January 23

Abbott Reports 16.1 Percent Sales Growth in Fourth Quarter Reps. Dingell, Stupak Continue Enhance Trial Inquiry Oversight and Government Reform Committee Chairman Waxman Requests FDA Provide Documents Regarding Drug Company Marketing Loophole Paul Capital Healthcare Purchases Additional Royalty Interest in GlaxoSmithKline's Rotarix Eisai Announces Satisfaction of Conditions to Tender Offer for MGI Pharma Shares Pfizer Reports Fourth-Quarter and Full-Year 2007 Results and 2008 Financial Guidance Bayer Establishes US Special Access Program for Leukine While Replacing Current Liquid Formulation Dalton Medicinal Chemistry Partners Achieves Another Milestone in Collaboration with Boehringer Ingelheim (Canada) Ltd. U.S. Federal Trade Commission Clears Global Licensing and Development Agreement Between BioMS Medical and Lilly Direvo to Collaborate with Medimmune on Therapeutic Protease for the Treatment of CNS Diseases U.S. Patent Office Rejects Key HIV/AIDS Drug Patents at PUBPAT Request: Government Finds Prior Art Submitted By PUBPAT Invalidates All of Gilead Sciences' Claims

January 25

Amgen's Fourth Quarter 2007 Adjusted Earnings Per Share (EPS) Increased 11 Percent to $1.00; Full Year 2007 Adjusted EPS Increased 10 Percent to $4.29 TransTech Pharma, Inc. Acquires Three Programs for the Treatment of Metabolic Disorders from Novo Nordisk Allergan, Inc. Comments on Botox (Botulinum Toxin Type A) Safety Profile ApoCell to Conduct Studies in Support of Novel Pfizer Cancer Drug Trial LabCorp Announces Definitive Agreement to Acquire Tandem Labs, Inc. EMEA Statement on the Safety of Gardasil Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Second Generation Niacin Receptor Agonist Under Its Collaboration With Merck & Co., Inc. EMEA Recommends New Warnings and Contraindications for Rosiglitazone Sen. Grassley Asks Questions About Controversy Over Delayed Release of Drug Study Involving Vytorin MicroIslet Announces Management Change and Receives Working Capital Loan FDA Issues Early Communication about an Ongoing Review of Vytorin

January 30

FDA Sends Warning Letter to Novartis Vaccines and Diagnostics Teva Announces Wyeth Voids Standstill Agreement on Generic Protonix Merck Announces 2007 Financial Results Reflecting Revenue Growth from Key Products Wyeth Announces Launch of Own Generic Version of Protonix Neose Announces Discontinuation of NE-180 Program Kyowa Hakko Nine-month Operating Income up 20.6%; Raises Full-year Forecasts Record Operating Results for Roche Again in 2007 Taisho Revises Earnings Forecasts for FY2007 Full Year Prasco to Distribute Wyeth's Own Generic Versions of Protonix Delayed-Release Tablets Allergan Reports Fourth Quarter Operating Results Common Drug-Releasing Coronary Stents Appear to Have Similar Clinical Outcomes Solvay Pharmaceuticals, Inc. Announces Retirement of CEO Laurence Downey and Appointment of Stephen Hill as New President and Chief Executive Officer

January 31

Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company ImClone Systems Reports Fourth Quarter and Full Year 2007 Financial Results Bristol-Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 PsychoGenics Expands Drug Discovery Relationship with Eli Lilly and Company Cell Therapeutics, Inc. (CTI) Cuts Net Operating Expenses 35% and Expands Commercial Team to Support Zevalin Sales and Applications Seeking Two Product Approvals in 2009 AstraZeneca PLC, Fourth Quarter and Full Year Results 2007 Novo Nordisk: Financial statement for 2007 Innate Pharma and Novo Nordisk A/S Partnership Refocused on the Inflammatory Field FDA MedWatch- Antiepileptic Drugs- FDA Analysis Showed Patients Receiving Antiepileptic Drugs Had Approximately Twice The Risk of Suicidal Behavior Or Ideation

Pharmaceutical Industry News Archive

More News Resources

Printable Version Email Recommend Tweet Save or Share
(web6)